[Funding] Arctic Therapeutics
Arctic Therapeutics raising a €12.5M-€20M equity round (figures differ within the proposal body); offers CerebrumDAO members a €75,000 co-investment slot within that round. Lead compound AT-001 targets hereditary cystatin C amyloid angiopathy and Alzheimer's.
Vote result
| Choice | Votes (NEURON) | Share |
|---|---|---|
| For | 8,955,337,920.01 | 100.0% |
| Against | 0 | 0.0% |
| Abstain | 0 | 0.0% |
Quorum: 3,870,000,000 NEURON